Clinical Trials Browser

Phase 2 × Leukemia × glasdegib × Clear all

NCT01842646 2021-06-14

Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)

Phase 2 Completed

35 enrolled 7 charts

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic